GO
Loading...

Boston Scientific Corp

More

  • These ‘Turkey Stocks’ Soaked in Tryptophan? Wednesday, 21 Nov 2012 | 2:58 PM ET

    There are 38 companies in the S&P 500 index that have not moved more than 2 percent positive or negative year-to-date.

  • World stocks lower ahead of EU summit conclusion Friday, 19 Oct 2012 | 5:09 AM ET

    Britain's FTSE 100 lost 0.1 percent to 5,910.04 in early trading. Microsoft said net income fell a worse-than-expected 22 percent to $4.47 billion in the fiscal first quarter, which ended Sept. 30. BB&T bank, Philip Morris International and Boston Scientific also reported results that fell short of forecasts.

  • Asia stocks mixed after US earnings disappoint Friday, 19 Oct 2012 | 1:41 AM ET

    Markets in mainland China, Singapore, Thailand, Indonesia and India were down. Microsoft said net income fell a worse-than-expected 22 percent to $4.47 billion in the fiscal first quarter, which ended Sept. 30. Microsoft shares fell in after-hours trading.

  • Asia stocks fall on US earnings disappointment Thursday, 18 Oct 2012 | 11:32 PM ET

    European Union leaders opened a two-day meeting in Brussels on Thursday and took a critical step by agreeing to create a banking supervisor to oversee institutions in the 17 countries using the euro. South Korea's Kospi lost 0.9 percent to 1,942.47 and Australia's S&P/ASX 200 fell 0.1 percent to 4,554.50.

  • News Summary: Google out early; Nasdaq falls Thursday, 18 Oct 2012 | 4:13 PM ET

    NOT FEELING LUCKY: Google inadvertently released a disappointing earnings report early, and its stock plunged. Google ended the day down more than $60 per share, or 8 percent. EARNINGS WATCH: BB&T, Philip Morris International and Boston Scientific all fell after reporting disappointing earnings.

  • Google issues a bad report early, hurting Nasdaq Thursday, 18 Oct 2012 | 4:09 PM ET

    NEW YORK-- Google plummeted almost $80 per share, more than 10 percent, and trading in the stock was halted two and a half hours Thursday after a disappointing earnings report was published ahead of schedule and surprised investors. Google was trading at $754 per share at 12:30 p.m. EDT, then fell almost $20 in a minute after investors saw the report, a draft.

  • Stocks slip after Google earnings, jobless claims Thursday, 18 Oct 2012 | 2:43 PM ET

    Google plunged 9 percent after it accidentally released a weak earnings report hours ahead of schedule. "This is a market that's waiting for a clear catalyst," said Quincy Krosby, market strategist at Prudential Financial. Google's stock dropped $68.19 to $687.30 before trading was suspended.

  • Boston Scientific swings to 3rd-quarter loss Thursday, 18 Oct 2012 | 10:42 AM ET

    WASHINGTON-- Medical device maker Boston Scientific said Thursday it swung to a third-quarter loss, as legal fees and restructuring expenses weighed down already-sluggish sales of the company's implants.

  • Stocks wobble after Amex earnings, jobless claims Thursday, 18 Oct 2012 | 10:23 AM ET

    NEW YORK-- The stock market headed slightly lower on Thursday, following a leap in claims for unemployment benefits and weak results from American Express. The increase suggested that layoffs were increasing, however the Labor Department noted that there were technical reasons behind the swing, mainly delayed figures from one large state, California.

  • Markets falter in run-up to EU summit Thursday, 18 Oct 2012 | 10:11 AM ET

    Though expectations have diminished in recent days that the 27- nation EU will agree on the terms of a banking union, investors are keen to hear updates on the economic fate of Spain, as well as Greece, which appears to be near to securing its next batch of bailout cash.

  • Stocks ease as earnings, jobless claims disappoint Thursday, 18 Oct 2012 | 9:42 AM ET

    Stocks are opening mostly lower, breaking a four-day winning streak for the Dow Jones industrial average, following a leap in claims for unemployment benefits and a mixed batch of corporate earnings reports. The Labor Department reported that applications for unemployment benefits jumped last week to the highest level in four months.

  • Oct 11- Belo Sun Mining Corp:. *Canaccord Genuity raises Belo Sun Mining Corp price target to C $2.50. Reuters Station users, click. 1568.

  • MARKET PULSE-Alcoa, Eli Lilly, Edwards Lifesciences Tuesday, 9 Oct 2012 | 7:34 AM ET

    **ALCOA INC, Monday close $9.12, up 0.5 pct post-market. **YUM BRANDS, Monday close $66.94,. **CHEVRON CORP, Monday close $117.62.

  • Oct 8- Boston Scientific Corp said it has agreed to pay $90 million to buy privately held Rhythmia Medical Inc to gain access to its three dimensional navigation system to assist doctors in performing complex heart procedures on patients with dangerously irregular heart rhythms.

  • Boston Scientific in deal to buy Rhythmia Medical Monday, 8 Oct 2012 | 5:55 PM ET

    NATICK, Mass.-- Boston Scientific Corp. said Monday it will buy Rhythmia Medical, which makes mapping and navigation systems used in heart surgeries, for up to $265 million.

  • After-Hours Buzz: EW, INTC, AA & More Monday, 8 Oct 2012 | 4:54 PM ET

    Check out which companies are making headlines after the bell Monday.

  • BRIEF-Boston Scientific to acquire Rhythmia Medical Monday, 8 Oct 2012 | 4:49 PM ET

    Oct 8- Boston Scientific Corp:. *To acquire Rhythmia Medical Inc. *Says once the mapping system is cleared by the U.S. Food and Drug Administration and receives CE Mark approval in Europe, Boston Scientific expects to begin a limited market launch of the system in 2013 and full market launch in 2014..

  • *Debt financing soars among larger medical device makers By Susan Kelly. CHICAGO, Oct 1- Venture capitalists, long the lifeblood of medical technology firms, are growing cautious on the sector after seeing their returns squeezed in a time of growing cost pressures for healthcare, a report by Ernst& Young said.

  • *Kevin Lobo succeeds interim CEO Curt Hartman* Hartman to leave company* CEO search had been under way since February* Stock falls 1.5 percent in afternoon trading By Toni Clarke. Oct 1- Medical device maker Stryker Corp on Monday named Kevin Lobo, head of its orthopedics unit, as president and chief executive following an eight-month search.

  • *Lobo succeeds interim CEO Curt Hartman* Hartman to leave company* CEO search had been underway since February* Stock falls 0.4 pct in midday trading By Toni Clarke. Oct 1- Medical device maker Stryker Corp on Monday named Kevin Lobo, head of its orthopedics unit, as president and chief executive following an eight-month search.